ALMS
ALUMIS INC.Company Information
- Company Name
- ALUMIS INC.
- CIK
- CIK0001847367
- Category
- <br>Emerging growth company
- Ticker: Exchange
- ALMS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ALMS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-08
- Last sale
- 2026-09-08
- Shares purchased (TTM)
- 4,036,692
- Shares sold (TTM)
- 116,084
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 113,481,507
- Shares outstanding
- 127,690,254
- Ownership
- 88.87%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -54.53%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 64 | 64 | 90 | 65 | 152 | 129 | 170 | 213 | 155 | ||||||
| Restricted Cash Current | - | 0 | 0 | - | 0 | - | - | - | 0 | ||||||
| Marketable Securities Current | - | - | 219 | 312 | 335 | 80 | 119 | 148 | 54 | ||||||
| Prepaid Expense And Other Assets Current | - | - | - | - | - | 4 | - | - | - | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | 439 | 459 | - | - | - | - | - | - | - | ||||||
| Assets Current | 514 | 532 | 318 | 393 | 518 | 226 | 306 | 377 | 225 | ||||||
| Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Noncurrent | - | 47 | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 17 | 18 | 18 | 19 | 20 | 20 | 21 | 21 | 22 | ||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | 9 | 51 | 51 | 51 | 51 | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 17 | 16 | 17 | 18 | 18 | 14 | 13 | 13 | 13 | ||||||
| Other Assets Noncurrent | 2 | 7 | 6 | 6 | 2 | 0 | 0 | 0 | 4 | ||||||
| Assets | 561 | 672 | 412 | 488 | 611 | 261 | 341 | 413 | 265 | ||||||
Liabilities Current | |||||||||||||||
| Accounts Payable Current | 13 | 12 | 10 | 5 | 15 | 7 | 10 | 6 | 9 | ||||||
| Contract With Customer Liability Current | 7 | 6 | 1 | - | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 5 | 4 | 5 | 4 | 4 | 3 | 2 | 1 | 2 | ||||||
| Liabilities Current | 76 | 71 | 73 | 65 | 86 | 60 | 51 | 34 | 33 | ||||||
| Operating Lease Liability Noncurrent | 32 | 31 | 32 | 33 | 35 | 29 | 29 | 30 | 30 | ||||||
| Contract With Customer Liability Noncurrent | - | - | 3 | 2 | 3 | 3 | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 0 | 2 | 2 | 2 | 2 | - | - | - | - | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Liabilities | 108 | 105 | 111 | 103 | 126 | 93 | 81 | 64 | 65 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | 639 | ||||||
| Common Stock Value | - | - | - | - | - | - | - | - | 0 | ||||||
Stockholders Equity | |||||||||||||||
| Additional Paid In Capital | 1,590 | 1,562 | 1,203 | 1,193 | 1,183 | 926 | 919 | 912 | 32 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -1,137 | -995 | -902 | -809 | -698 | -758 | -659 | -564 | -471 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | ||||||
| Stockholders Equity | 452 | 567 | 301 | 385 | 485 | 168 | 260 | 348 | -439 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | 0 | 0 | 203 | ||||||
| Liabilities And Stockholders Equity | 561 | 672 | 412 | 488 | 611 | 261 | 341 | 413 | 265 | ||||||
| Common Class A | - | - | - | - | - | - | - | - | 29 | ||||||
| Common Class B | - | - | - | - | - | - | - | - | 7 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | 0 | 0 | 168 | ||||||
| Temporary Equity Shares Outstanding | - | - | 0 | - | - | - | 0 | 0 | 168 | ||||||
| Voting Common Stock | 0 | 0 | 6 | 0 | 0 | 0 | 7 | 0 | - | ||||||
| Nonvoting Common Stock | 0 | 0 | 6 | 0 | 0 | 0 | 7 | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Temporary Equity Liquidation Preference | - | - | - | - | - | - | 0 | 0 | 630 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialALUMIS INC. (ALMS) — SEC Financial Statements & Analysis
ALUMIS INC. (ALMS) is a pharmaceutical preparations company, incorporated in DE. ALUMIS INC. trades on Nasdaq as: ALMS. ALUMIS INC. (ALMS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, ALUMIS INC. carries a market cap of $3.59B, a P/E ratio of -8.19x, a P/B ratio of 7.95x, a P/S ratio of 485.70x, an enterprise value of $3.53B, and an EV/EBITDA multiple of -7.75x. On profitability, it posts an operating margin of -6204.39%, a net margin of -5933.45%, a Return on Equity (ROE) of -93.65%, a Return on Assets (ROA) of -74.94%, and a Return on Invested Capital (ROIC) of -127.05%. Per share, it reports EPS of $-3.44, diluted EPS of $-3.44, free cash flow per share of $-2.76, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -63.11% year-over-year, net income growth of 58.26% year-over-year, and EPS growth of -5.21% year-over-year. On the balance sheet, it maintains a current ratio of 6.74x, a quick ratio of 6.74x, working capital of $437.85M, a debt-to-equity ratio of 0.24x, a debt ratio of 0.19, free cash flow of $-351.80M (TTM), and net debt of $-63.71M. Figures sourced from SEC EDGAR.
- Market Cap
- $3.59B
- P/E TTM
- -8.19x
- EPS TTM
- $-3.44
- P/B TTM
- 7.95x
- ROE TTM
- -93.65%
- ROA TTM
- -74.94%
- Debt To Equity
- 0.24x
- Free Cash Flow TTM
- $-351.80M
- Net Revenue TTM Growth 1Y
- -63.11%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ALUMIS INC. in?
ALUMIS INC. (ALMS) operates in the Pharmaceutical Preparations industry.
What exchange does ALMS trade on?
ALUMIS INC. (ALMS) trades on the Nasdaq.
Where is ALUMIS INC. incorporated?
ALUMIS INC. is incorporated in DE.
When was ALUMIS INC. (ALMS)'s most recent SEC filing?
ALUMIS INC. (ALMS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is ALMS's market cap?
ALUMIS INC. (ALMS) has a market capitalization of $3.59B as of 2026-06-30.
What is ALMS's EPS (earnings per share)?
ALUMIS INC. (ALMS)'s trailing twelve month EPS is $-3.44 as of 2026-06-30.
What is ALMS's ROE (return on equity)?
ALUMIS INC. (ALMS)'s trailing twelve month Return on Equity (ROE) is -93.65% as of 2026-06-30.
What is ALMS's ROA (return on assets)?
ALUMIS INC. (ALMS)'s trailing twelve month Return on Assets (ROA) is -74.94% as of 2026-06-30.
What is ALMS's ROIC (return on invested capital)?
ALUMIS INC. (ALMS)'s trailing twelve month Return on Invested Capital (ROIC) is -127.05% as of 2026-06-30.
What is ALMS's EV/EBITDA?
ALUMIS INC. (ALMS)'s trailing twelve month EV/EBITDA is -7.75x as of 2026-06-30.